πŸ‡ΊπŸ‡Έ FDA
Patent

US 9090586

Heterocyclic compound

granted A61KA61K9/00A61K9/2018

Quick answer

US patent 9090586 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K9/00, A61K9/2018, A61K9/2059, A61P